Diabetes care continues to evolve, with American Diabetes Association guidelines placing greater emphasis on SGLT-2 and GLP-1 medications. This session explores how these agents improve blood glucose management while reducing the risk of diabetes-related complications. Participants will discuss clinical updates, implementation strategies, and real-world lessons from a state prison system working to expand access, monitor outcomes, and integrate these treatments across correctional health care settings.

Educational Objectives

• Demonstrate guideline-directed management strategies for type 2 diabetes
• Apply American Diabetes Association type 2 diabetes management guidelines
• Plan strategies to implement and monitor guideline-directed type 2 diabetes care

Level:Intermediate